Citadel Advisors’s Chemed CHE Stock Holding History

Citadel Advisors’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.9M	Buy	25,600 +23,500	+1,119%	+$9.88M	﹤0.01%	3290
2026 Q1	$793K	Sell	2,100 -500	-19%	-$214K	﹤0.01%	8207
2025 Q4	$1.11M	Buy	2,600 +800	+44%	+$348K	﹤0.01%	7163
2025 Q3	$806K	Buy	+1,800	New	+$815K	﹤0.01%	8016

Other funds holding CHE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Citadel Advisors's CHE Position: Q2 2026 in Review

Citadel Advisors sold out of Chemed (CHE) in Q2 2026, closing a stake of 114,119 shares — an estimated $48M sold.

Citadel Advisors first reported a position in CHE in Q2 2013 and held it in 39 quarters. The position peaked at $65.1M in Q4 2020. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

Citadel Advisors reported no remaining Chemed position as of Q2 2026 after selling out during the quarter.
Citadel Advisors sold 114,119 Chemed shares in Q2 2026, an estimated $48M.
Citadel Advisors first reported a position in Chemed in Q2 2013 and held it in 39 quarters.
Citadel Advisors's Chemed position peaked at $65.1M in Q4 2020.
532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.